The use of radiopharmaceuticals in neurological applications is an opportunity.
Nuclear medicine is mostly used to diagnose cardiovascular disease and cancer. Because Radiopharmaceuticals in the Nuclear Medicine Markets are saturated, a number of companies and stakeholders have decided to focus their efforts on growing total radiopharmaceutical usage. Radiopharmaceuticals' demand and uptake are projected to rise in the next years as their application areas grow. This suggests that businesses can broaden their product lines and Radiopharmaceuticals in the Nuclear Medicine Market share by responding to the demand for radiopharmaceuticals in neurological applications.
Budget cuts in hospitals and hefty equipment expenses pose a challenge.
The COVID-19 pandemic has wreaked devastation around the planet, disrupting healthcare systems around the world. As a result, hospitals have increased testing efforts in an effort to preserve lives and prevent the virus from spreading further. COVID-19's financial troubles led governments all across the world to impose budget cuts. In addition, the pandemic resulted in lower patient volumes for nuclear medicine operations and the cancellation of elective procedures, putting hospitals in a financial bind.
Read more @ https://cmilatestinsights.blogspot.com/2021/11/global-radiopharmaceuticals-in-nuclear.html
